ASML vs SER · P/E 57, $665.37B cap vs rev $56.0K
ASML Holding NV ADR (ASML) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
ASML does not have a complete income-statement cache yet.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. SER currently screens at market cap $29.7M.
Not investment advice. Open the ASML and SER stock pages for the full models.
Not investment advice.